8372 Stock Overview
An investment holding company, engages in supplying of medical devices in Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Grand Brilliance Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.093 |
| 52 Week High | HK$0.12 |
| 52 Week Low | HK$0.081 |
| Beta | 0.29 |
| 11 Month Change | 2.20% |
| 3 Month Change | 1.09% |
| 1 Year Change | -7.00% |
| 33 Year Change | 14.81% |
| 5 Year Change | 14.81% |
| Change since IPO | -76.75% |
Recent News & Updates
Shareholders Will Probably Hold Off On Increasing Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation For The Time Being
Sep 04
Grand Brilliance Group Holdings (HKG:8372) Strong Profits May Be Masking Some Underlying Issues
Jul 18Recent updates
Shareholders Will Probably Hold Off On Increasing Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation For The Time Being
Sep 04Grand Brilliance Group Holdings (HKG:8372) Strong Profits May Be Masking Some Underlying Issues
Jul 18Earnings Not Telling The Story For Grand Brilliance Group Holdings Limited (HKG:8372)
May 09Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Oct 31Grand Brilliance Group Holdings (HKG:8372) Will Be Hoping To Turn Its Returns On Capital Around
Sep 21Grand Brilliance Group Holdings (HKG:8372) Will Want To Turn Around Its Return Trends
Oct 28Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Aug 29A Look At The Fair Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Apr 29Returns On Capital At Grand Brilliance Group Holdings (HKG:8372) Paint A Concerning Picture
Mar 16Increases to Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation Might Cool off for now
Sep 10Weak Statutory Earnings May Not Tell The Whole Story For Grand Brilliance Group Holdings (HKG:8372)
Jul 02Grand Brilliance Group Holdings (HKG:8372) Could Be Struggling To Allocate Capital
May 11Is Now The Time To Put Grand Brilliance Group Holdings (HKG:8372) On Your Watchlist?
Mar 17We're Watching These Trends At Grand Brilliance Group Holdings (HKG:8372)
Feb 08
Have Grand Brilliance Group Holdings Limited (HKG:8372) Insiders Been Selling Their Stock?
Dec 31Shareholder Returns
| 8372 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 1.1% | -1.5% | -0.6% |
| 1Y | -7.0% | -27.6% | 9.6% |
Return vs Industry: 8372 exceeded the Hong Kong Healthcare industry which returned -27.6% over the past year.
Return vs Market: 8372 underperformed the Hong Kong Market which returned 9.6% over the past year.
Price Volatility
| 8372 volatility | |
|---|---|
| 8372 Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 8372 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8372's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 50 | Bikie Wong | www.grandbrilliancegroup.com |
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. The company offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. It also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance and after sale services, as well as holds trademarks.
Grand Brilliance Group Holdings Limited Fundamentals Summary
| 8372 fundamental statistics | |
|---|---|
| Market cap | HK$74.40m |
| Earnings (TTM) | HK$8.45m |
| Revenue (TTM) | HK$82.29m |
8.8x
P/E Ratio0.9x
P/S RatioIs 8372 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8372 income statement (TTM) | |
|---|---|
| Revenue | HK$82.29m |
| Cost of Revenue | HK$40.28m |
| Gross Profit | HK$42.01m |
| Other Expenses | HK$33.56m |
| Earnings | HK$8.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 51.05% |
| Net Profit Margin | 10.27% |
| Debt/Equity Ratio | 0% |
How did 8372 perform over the long term?
See historical performance and comparison